Pre-market: Watch out for Essar Oil, MRPL, JKumar Infra

Markets are likely to open marginally higher but further gains may be capped on profit taking

SI Reporter Mumbai
Last Updated : May 21 2014 | 8:34 AM IST
Markets are likely to open marginally higher but further gains may be capped as investors are likely to continue profit booking in cyclicals after sharp gains recently.

At 8:25AM, the SGX Nifty was up 20 points at 7,310.

Asian shares were trading mixed tracking overnight losses on Wall Street. Meanwhile, the Bank of Japan has kept its key policy rates unchanged. The Shanghai Composite and Hang Seng were trading with marginal gains while the Nikkei and Straits Times were down 0.3% each.

Also Read

US stocks ended lower on Tuesday on talks that the Federal Reserve would hike policy rates sooner-than-expected and weak earnings from retailers. The Dow Jones ended down 0.8% at 16,374, S&P 500 lost 0.7% at 1,873 and the tech-laden Nasdaq ended down 0.7% at 4,097.

Stocks in focus

Punj Lloyd will be under pressure on disappointing fourth quarter earnings on the back of higher interest costs.

Luggage carrier maker VIP Industries today reported over three-fold increase in consolidated net profit at Rs 20.3 crore in the fourth quarter ended March 31, 2014 on the account of exceptional income.

Mangalore Refinery and Petrochemicals Ltd (MRPL) today reported a net profit of Rs 1067 crore in the fourth quarter on back of foreign exchange and inventory gains.

Higher refining margins and foreign exchange gains helped Ruias-promoted Essar Oil, India's second-largest private refiner, post a five-fold jump in fourth-quarter net profit. The company reported a net profit of Rs 1,008 crore in the January-March 2014 quarter, up from Rs 200 crore a year earlier. During the quarter, Essar's Gross refining margin or converting every barrel of crude oil into fuel stood at $10.12 per barrel against $9.06 during the January-March 2013 quarter.

J Kumar Infra will see some action on the back of robust Q4 numbers and orders worth Rs 467.5 crore.

The US Food and Drug Administration (FDA), in a letter dated May 7, warned Sun Pharmaceutical the responses given by it on the import alert on its Karkhadi plant in Gujarat lacked sufficient corrective actions.

Essar Shipping may see some pressure after the company announced dismal results for Q4 with consolidated net loss of Rs 165.7 crore and sharp decline in revenues to Rs 480 crore from Rs 729 crore in the same quarter last fiscal.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 21 2014 | 8:30 AM IST

Next Story